###begin article-title 0
###xml 15 26 15 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
Lola regulates Drosophila olfactory projection neuron identity and targeting specificity
###end article-title 0
###begin p 1
This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 87 98 87 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
Precise connections of neural circuits can be specified by genetic programming. In the Drosophila olfactory system, projection neurons (PNs) send dendrites to single glomeruli in the antenna lobe (AL) based upon lineage and birth order and send axons with stereotyped terminations to higher olfactory centers. These decisions are likely specified by a PN-intrinsic transcriptional code that regulates the expression of cell-surface molecules to instruct wiring specificity.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 25 47 25 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">longitudinals lacking </italic>
###xml 48 52 48 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 223 231 223 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 298 303 298 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 430 435 430 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 464 469 464 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 527 532 527 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 651 656 651 656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lim1 </italic>
We find that the loss of longitudinals lacking (lola), which encodes a BTB-Zn-finger transcription factor with 20 predicted splice isoforms, results in wiring defects in both axons and dendrites of all lineages of PNs. RNA in situ hybridization and quantitative RT-PCR suggest that most if not all lola isoforms are expressed in all PNs, but different isoforms are expressed at widely varying levels. Overexpression of individual lola isoforms fails to rescue the lola null phenotypes and causes additional phenotypes. Loss of lola also results in ectopic expression of Gal4 drivers in multiple cell types and in the loss of transcription factor gene lim1 expression in ventral PNs.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 191 195 191 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 195 199 195 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 217 222 217 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
Our results indicate that lola is required for wiring of axons and dendrites of most PN classes, and suggest a need for its molecular diversity. Expression pattern changes of Gal4 drivers in lola-/- clones imply that lola normally represses the expression of these regulatory elements in a subset of the cells surrounding the AL. We propose that Lola functions as a general transcription factor that regulates the expression of multiple genes ultimately controlling PN identity and wiring specificity.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 250 251 250 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 405 406 405 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 425 426 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 474 485 474 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 590 591 590 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 762 764 762 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 779 780 779 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 781 782 781 782 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 964 965 964 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 966 967 966 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1343 1344 1343 1344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1566 1567 1566 1567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
Nervous systems exhibit highly reproducible patterns of connectivity that are essential for their proper functions. Axon pathfinding in many systems is heavily dependent upon genetically programmed expression of guidance factors and their receptors [1]. Recent studies have indicated that dendrite target selection and aspects of synapse specificity can also be precisely genetically programmed in flies [2] and vertebrates [3]. For example, wiring specificity in the adult Drosophila olfactory system is achieved during pupal development before the onset of olfactory receptor expression [4]. Olfactory receptor neurons (ORNs) project their axons to glomeruli in the antennal lobe (AL), where they synapse with the dendrites of projection neurons (PNs) (Figure 1a; reviewed in [5,6]). PNs target their dendrites to single glomeruli and send their axons to stereotypic locations in the mushroom body (MB) and lateral horn (LH) according to their glomerular class [7-9]. Most PNs are derived from three neuroblast lineages, anterodorsal (adPNs), lateral (lPNs) and ventral (vPNs). adPNs and lPNs innervate intercalating but non-overlapping sets of glomeruli, suggesting lineage-specific control of targeting. Additionally, adPNs are specified by birth order, suggesting that instructive information within a lineage determines wiring patterns [2]. Indeed, PN dendritic patterning precedes ORN axon patterning: by the time pioneering ORN axons arrive at the developing AL, PN dendrites have already formed a coarse map by virtue of their specific dendritic targeting [4].
###end p 9
###begin p 10
###xml 4 15 4 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 69 73 69 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 105 116 105 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 448 452 448 452 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 484 489 484 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 495 500 495 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 580 583 580 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 589 594 589 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 887 893 887 893 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c-g) </bold>
###xml 1501 1508 1501 1508 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(h, i) </bold>
###xml 1551 1555 1551 1555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 1555 1559 1555 1559 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1560 1565 1560 1565 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ore76</italic>
###xml 1876 1877 1876 1877 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1906 1910 1906 1910 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 1910 1914 1910 1914 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1981 1982 1981 1982 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2020 2021 2020 2021 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 2029 2030 2029 2030 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
The Drosophila olfactory system, the lola gene, and Lola expression. (a) Schematic representation of the Drosophila antennal lobe. Olfactory receptor neuron (ORN) axons project to stereotyped glomeruli in the antennal lobe (AL). The anterodorsal (ad), lateral (l) and ventral (v) lineages of Gal4-GH146 positive PNs send dendrites to specific glomeruli in the AL and axons to specific regions in the mushroom body (MB) calyx and lateral horn (LH). (b) Schematic representation of the lola gene. lola is a complex genetic locus consisting of at least 20 isoforms generated by both cis- and trans-splicing of an amino-terminal BTB domain-containing common region to unique carboxy-terminal exons, most of which contain Zn fingers. Individual isoforms are labeled in accordance with previous nomenclature [16]. Mutations are marked by asterisks and isoforms with UAS transgenes are listed. (c-g) Time course of Lola expression using an antibody generated against the common region (amino acids 19-467). Lola is expressed in all neurons adjacent to the AL at all stages of development, shown at 24 h after larval hatching (ALH), 72 h ALH, 0 h after puparium formation (APF), 18 h APF and adult. Lola is also expressed in the neuroblast (arrow in c). In this and all subsequent figures, non-overlapping fluoresence channels are pseudocolored for ease of viewing: anti-CD8::GFP in green, anti-Lola in magenta. Dashed vertical line marks the midline. Antenna lobe (AL) outlined with thin dashed line in (g). (h, i) Specificity of anti-Lola antibody. Lateral lola-/- (ore76) MARCM clone stained with anti-pan Lola. In (h), the white outline denotes entire MARCM clone determined by loss of Lola staining. The yellow outline denotes boundary of GH146 positive cells based on GFP expression. Loss of Lola staining in GH146 cells can be seen clearly in the magenta (Lola) only channel (h2). In (i), a DL1 single-cell lola-/- MARCM clone shows a loss of Lola staining in the magenta channel (i2). The arrow marks the same cell in (i1) and (i2). Scale 10 mum. Green, anti-CD8::GFP; magenta, anti-Lola; blue, DAPI.
###end p 10
###begin p 11
###xml 344 346 344 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 347 349 347 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 733 735 733 735 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1006 1008 1006 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1200 1202 1200 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1310 1317 1310 1317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">chinmo </italic>
###xml 1438 1440 1438 1440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1756 1758 1756 1758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
Several cell-surface proteins, including Sema-1a, Dscam and N-Cadherin, have been shown to play different roles in PN dendritic development. These studies suggest a model in which PN dendrites first target to a rough region of the AL based on molecular gradients and then are further refined by dendro-dendritic and dendro-axonal interactions [10-12]. The expression of these and additional cell-surface proteins are likely controlled by a transcriptional code that acts to uniquely specify the wiring aptitude of individual PNs[13,14]. Studies of several transcription factors (TFs) support the existence of a transcriptional hierarchy in PNs. Some factors, such as the LIM cofactor Chip, appear to affect wiring in all PN classes [14]. Other TFs show lineage specific restriction in expression and regulatory effects. For example, the LIM-homeodomain TF Islet is required for proper targeting of a subset of adPNs and lPNs, while the homeodomain TF Cut is required in only a subset of lPNs and all vPNs [14]. As another example, POU-domain TFs Acj6 and Drifter have restricted expression patterns in adPN and lPN lineages, respectively, and control wiring specificity in their respective lineages [13]. A recently identified BTB-Zn-finger TF, Chinmo, regulates birth order-dependent wiring of adPNs. Loss of chinmo results in adPNs born in early larval life acquiring the targeting specificity of late-born PNs within the same lineage [15]. There are also TFs that appear to affect targeting of a single PN type. For example, the LIM-homeodomain TF Lim1 is necessary for proper targeting of a single vPN to the DA1 glomerulus, and is regulated by Cut. The Zn-finger TF Squeeze appears to be necessary for the innervation of a single lPN glomerulus, DM5 [14]. All these studies support a model where the targeting specificity of a particular PN is regulated by a unique complement of TFs, and additional members of the TF code remain to be identified.
###end p 11
###begin p 12
###xml 9 31 9 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">longitudinals lacking </italic>
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 134 136 134 136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 285 290 285 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trans</italic>
###xml 299 302 299 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 515 517 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 525 530 525 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 589 590 589 590 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 591 593 591 593 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 630 631 630 631 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 699 701 699 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 702 704 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 754 756 754 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1017 1019 1017 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1020 1022 1020 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1106 1108 1106 1108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 947 952 <span type="species:ncbi:4932">yeast</span>
The gene longitudinals lacking (lola) encodes a molecularly diverse BTB-Zn-finger TF with at least 20 unique protein isoforms (Figure 1b). Each isoform is formed by combining a set of common BTB-containing amino-terminal exons to unique Zn-finger-containing carboxy-terminal exons via trans- and/or cis-pre-mRNA splicing [16-18]. The BTB (Broad complex, Tramtrack, Bric a brac) domain, also referred to as the POZ (poxvirus and Zn-finger) domain, is a common domain likely involved in protein-protein interactions [19]. Most lola isoforms have one or more unique Zn-fingers of either the C2H2 type that binds DNA, or the unusual C2HC class that binds nucleosomes, non-histone proteins, RNA and DNA [20,21]. At least some Lola isoforms bind DNA directly [22]. Interestingly, three Lola isoforms lack Zn-fingers and theoretically could be involved in heteromeric regulatory interactions with other Lola isoforms, as Lola was found to bind itself in yeast-two-hybrid interactions and co-immunoprecipitation experiments [21,23]. Lola also likely interacts with other proteins such as chromosomal kinase JIL-1 [21].
###end p 12
###begin p 13
###xml 205 210 205 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 356 358 356 358 <sub xmlns:xlink="http://www.w3.org/1999/xlink">b </sub>
###xml 387 389 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 390 392 390 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 477 482 477 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 498 500 498 500 <sub xmlns:xlink="http://www.w3.org/1999/xlink">b </sub>
###xml 576 578 576 578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 581 586 581 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 683 685 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 688 693 688 693 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 827 832 827 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Notch</italic>
###xml 834 838 834 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">slit</italic>
###xml 844 849 844 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">robo </italic>
###xml 850 852 850 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 853 855 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 858 863 858 863 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 1054 1058 1054 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cut </italic>
###xml 1059 1061 1059 1061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
Lola was initially identified as a factor that regulates axon guidance in the embryonic central nervous system longitudinal tracks, and is reported to function in a wide array of other cellular processes. lola mutants exhibit defects in the extension of embryonic longitudinal axons and midline crossing, orientation of lateral chordotonal neurons, and ISNb axon growth and elaboration [24,25]. Mutation of Lola isoforms K or L is sufficient to inactivate a specific subset of lola functions in ISNb neurons, suggesting that different Lola isoforms may have unique functions [16]. lola was recently identified to disrupt ORN axonal innervation of the AL in an overexpression screen [26]. lola may exert its effect through transcriptional regulation of cell-surface molecules, and has been reported to genetically interact with Notch, slit, and robo [27,28]. lola may have a more general regulatory role as a polycomb group (PcG) factor affecting cell proliferation via the Notch pathway and regulating wing development through a genetic interaction with cut [29].
###end p 13
###begin p 14
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 96 101 96 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 228 239 228 239 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola T </italic>
###xml 243 253 243 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola L</italic>
###xml 263 273 263 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola A</italic>
###xml 337 342 337 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 381 386 381 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 576 581 576 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 750 755 750 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 772 776 772 776 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lim1</italic>
###xml 837 842 837 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
In this study, we show that lola plays an essential role in PN identity and wiring specificity. lola appears to be a general factor that affects wiring of both axons and dendrites in all three lineages of PNs. Overexpression of UAS-lola T and UAS-lola L, but not UAS-lola A, results in wiring defects. Additionally, expression of single lola isoforms is insufficient to rescue the lola null phenotype and often causes additional defects specific to the isoforms expressed, suggesting the importance of Lola molecular diversity in regulating PN wiring specificity. Indeed most lola isoforms are expressed in PNs but at different levels. Finally, consistent with previous findings of transcriptional regulation and potential PcG function, we find that lola likely regulates lim1and several Gal4 enhancer trap lines in PNs. We suggest that lola regulates PN wiring through transcriptional regulation of downstream targets involved in defining neuronal identity and targeting specificity.
###end p 14
###begin title 15
Results and discussion
###end title 15
###begin p 16
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 209 210 209 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 271 272 271 272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 273 274 273 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 284 286 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1a</xref>
###xml 312 317 312 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
We investigated the function of lola in wiring specificity of olfactory PNs by using the MARCM (mosaic analysis with a repressible cell marker) system [30]. PNs send dendrites to specific glomeruli in the AL [2] and axons to the MB and LH in highly stereotyped patterns [7-9] (Figure 1a), allowing us to examine lola function in both dendrites and axons.
###end p 16
###begin title 17
Lola is expressed in projection neurons and neuroblasts
###end title 17
###begin p 18
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 212 216 212 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1c&#8211;g</xref>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1c</xref>
###xml 499 504 499 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 517 522 517 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ore76</italic>
###xml 608 610 608 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 638 642 638 642 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 642 645 642 645 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 664 668 664 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1h,i</xref>
###xml 824 838 824 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-mCD8::GFP </italic>
###xml 980 982 980 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1h</xref>
Using a specific antibody raised against the domain common to all Lola isoforms (Figure 1b), we found that Lola is expressed in all cells in the AL region at all stages of development from larva to adult (Figure 1c-g). These include expression in post-mitotic cells such as PNs, but also in neuroblasts, which we can identify by their size during larval development (Figure 1c). Antibody specificity was confirmed by loss of Lola staining in neuroblast and single-cell MARCM clones homozygous for a lola null allele (ore76, which introduces an early stop codon in the BTB domain of all Lola isoforms (Figure 1b), hereafter referred to as lola-/-) in adult (Figure 1h,i) and in early pupa (data not shown). Note that Lola staining can be used to identify all mutant cells in a MARCM clone that are not necessarily labeled by UAS-mCD8::GFP because Lola is expressed ubiquitously throughout the brain, while Gal4 enhancer traps often have a more limited domain of expression (Figure 1h).
###end p 18
###begin title 19
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
lola mutant projection neurons have dendrite wiring defects
###end title 19
###begin p 20
###xml 190 194 190 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 194 198 194 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 422 423 422 423 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
Since Lola is expressed in PNs during AL development, and mutant clones effectively eliminate Lola protein during the period of dendritic targeting, we proceeded to analyze the phenotype of lola-/- PN MARCM clones. Using the Gal4-GH146 enhancer-trap line to label PNs, we observed wiring defects in all lineages of PN MARCM clones as well as anterodorsal single cell clones that normally target the DL1 glomerulus (Figure 2).
###end p 20
###begin p 21
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 35 39 35 39 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 87 91 87 91 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 113 117 113 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 117 121 117 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 121 125 121 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 492 496 492 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 496 499 496 499 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 654 655 653 654 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 652 657 651 656 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c<sub>1</sub>) </bold>
###xml 832 833 831 832 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 830 835 829 834 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c<sub>2</sub>) </bold>
###xml 1081 1082 1080 1081 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 1270 1274 1269 1273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 1274 1278 1273 1277 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1403 1407 1402 1406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 1407 1411 1406 1410 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
Dendritic targeting defects in lola-/- MARCM clones. Representative confocal images of (a) wild-type control and (b) lola-/- anterodorsal (1), lateral (2), or ventral (3) MARCM neuroblast (NB) clones or DL1 single cell (SC) clones (4) labeled with Gal4-GH146, and anterodorsal (5) and lateral (6) neuroblast clones labeled with Gal4-Mz19. Blue arrows and circles demark a loss of correct targeting, while yellow arrows and circles demark off-target innervation. Both anterodorsal and ventral lola-/-clones have ectopic dendritic extensions to the suboesophageal ganglion (SOG). anti-CD8::GFP in green, anti-nc82 neuropil in magenta. Scale bar, 20 mum. (c1) Normal targets of Gal4-GH146 in anterior, middle and posterior sections of the AL. Red denotes dorsal target, blue denotes lateral target, and green denotes ventral target. (c2) Quantification of adNB, lNB, vNB and DL1 clone phenotypes. The percentage of clones targeting a particular glomerulus is denoted on the Y-axis, while individual glomeruli are listed on the X-axis and grouped according to lineage by color as in (c1). Glomeruli in orange are not normally targeted by Gal4-GH146 positive PNs by heatshocking at 24 h ALH. Control clone innervation is denoted by colored bars corresponding to lineage, and lola-/- clone innervation is denoted by black bars. Note the decrease of correct targeting and increase of off-target innervation in lola-/- brains for all clone types. Additionally, the final 'diffuse' bar quantifies the number of brains that exhibit diffuse and wandering dendrites that fail to specifically innervate glomeruli.
###end p 21
###begin p 22
###xml 191 192 191 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 202 211 202 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2a1,a2,c1</xref>
###xml 240 244 240 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 244 248 244 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 433 439 433 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2b1,b2</xref>
###xml 788 792 788 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 792 796 792 796 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 973 976 973 976 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2c2</xref>
###xml 979 983 979 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 983 987 983 987 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1143 1147 1143 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 1147 1151 1147 1151 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1267 1276 1267 1276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2b1,b3,c2</xref>
###xml 1385 1388 1385 1388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2a3</xref>
###xml 1391 1395 1391 1395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 1395 1399 1395 1399 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1509 1515 1509 1515 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2b3,c2</xref>
###xml 1669 1672 1669 1672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2c2</xref>
###xml 1707 1711 1707 1711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 1711 1714 1711 1714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ore</italic>
###xml 1715 1716 1715 1716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1711 1718 1711 1718 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ore</italic>5<italic>D</italic>2 </sup>
###xml 1728 1732 1728 1732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 1816 1821 1816 1821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 1838 1840 1838 1840 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 1843 1847 1843 1847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 1847 1850 1847 1850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ore</italic>
###xml 1851 1852 1851 1852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1847 1854 1847 1854 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ore</italic>5<italic>D</italic>2 </sup>
###xml 1908 1914 1908 1914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ore76 </italic>
###xml 1947 1948 1947 1948 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 2016 2020 2016 2020 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
In wild type, Gal4-GH146 labels PNs of three neuroblast lineages. PNs from adPN and lPN lineages target their dendrites to stereotypical, intercalating but non-overlapping sets of glomeruli [2] (Figure 2a1,a2,c1). In general, phenotypes of lola-/- adPNs and lPNs can be classified into two main categories: a loss of targeting to normal target glomeruli and a gain of targeting to off-target (ectopically targeted) glomeruli (Figure 2b1,b2). However, the phenotypes are highly variable between brains and there are few consistent 'shifts' where one off-target glomerulus is innervated in place of a normal target. The phenotypes also have variable penetrance, with innervation of both normal and ectopic targets ranging from partial to full innervation from brain to brain. Specifically, lola-/- adPNs often invade DA1, DL3 and VA4, which are normal lPN targets. Likewise, mutant lPNs often innervate VA1d, VA1lm, DM6, D, DC2 and VM7, which are normal adPN targets (Figure 2c2). lola-/- dendrites also appear more diffuse in general, and often 'wander' through the lobe, wrapping around, but not actually innervating, glomeruli. Additionally, lola-/- dendrites are frequently not restricted to the AL and innervate regions of the suboesophageal ganglion (SOG; Figure 2b1,b3,c2). Wild-type vPNs strongly innervate DA1 and VA1lm, and one vPN (pan-AL PN) innervates the entire AL (Figure 2a3). lola-/- vPNs show a strong loss of AL restriction and nearly 37% show ectopic dendritic extensions to the SOG (Figure 2b3,c2). Additionally, DA1 targeting in ventral clones is almost completely lost (6% versus 82% in wild type) and VA1lm targeting is reduced nearly 30% (Figure 2c2). We also analyzed an independent lolaore5D2 allele of lola, which is predicted to be strongly hypomorphic due to a P-element insertion in the lola promoter (Figure 1b). lolaore5D2 clones display many of the phenotypes observed in the ore76 null allele (see additional file 1), indicating that the phenotypes we observed are caused by loss of lola.
###end p 22
###begin p 23
###xml 323 328 323 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 405 409 405 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 409 413 409 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 467 473 467 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2b4,c2</xref>
###xml 746 747 746 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 942 947 942 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
Given that Lola is ubiquitously expressed, dendritic defects in neuroblast clones can be attributed to its requirement in the neuroblast or post-mitotic cells or both; furthermore, one cannot determine cell autonomy with certainty. We therefore examined single cell clones that target to the DL1 glomerulus to test whether lola has a cell-autonomous and post-mitotic function. We found that nearly 80% of lola-/- DL1 single cell clones show targeting defects (Figure 2b4,c2) and 23% completely fail to innervate DL1. Another 54% innervate DL1 (though often weakly or partially) and have additional extensions either wandering between glomeruli or, more frequently, innervating glomeruli anterior to DL1 in the AL (see Table S1 in additional file 2). Using the pan-Lola antibody, we can verify there are no unlabeled clones in the vicinity of the AL and be certain we are looking at cell-autonomous effects. At least in the DL1 PN, therefore, lola appears to have post-mitotic, cell intrinsic effects on dendritic targeting.
###end p 23
###begin p 24
###xml 218 219 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 260 264 260 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 264 268 264 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 354 358 354 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 358 362 358 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 513 518 513 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2b5,6</xref>
###xml 719 722 719 722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2c2</xref>
###xml 786 790 786 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 790 794 790 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 865 869 865 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 869 873 869 873 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 917 921 917 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 921 925 921 925 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1005 1009 1005 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
To extend higher resolution phenotypic analysis to other PN classes, we examined adPN and lPN neuroblast clones using Gal4-Mz19, which labels a small subset of GH146-positive neurons that project to DA1, VA1d and DC3 [4]. Interestingly, dendritic targeting of lola-/- DA1 and VA1d PNs exhibit phenotypes with much less severity and penetrance than other lola-/- PNs. Normal target glomeruli were almost always strongly targeted, and defects mainly consisted of additional dendritic extensions into the AL (Figure 2b5,6). Consistent with this, we find that DA1 (innervated by lPNs) and VA1d (innervated by adPNs) are two of the most 'stable' glomeruli and show little phenotype in GH146 mutant neuroblast clones (Figure 2c2). These two glomeruli are also often ectopically innervated by lola-/- PNs from the opposite lineage (that is, DA1 is ectopically targeted by lola-/- adPNs while VA1d is ectopically targeted by lola-/- lPNs). This experiment suggests that distinct PN classes differentially require lola.
###end p 24
###begin p 25
###xml 58 63 58 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 77 82 77 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">orc4 </italic>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 173 174 173 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 176 177 176 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 182 183 182 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S8">8</xref>
###xml 190 197 190 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ore119 </italic>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1b</xref>
###xml 288 292 288 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 292 296 292 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 317 318 317 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 321 327 321 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola L</italic>
###xml 327 331 327 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 542 549 542 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola L </italic>
###xml 654 661 654 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola L </italic>
###xml 694 701 694 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ore119 </italic>
###xml 737 748 737 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola L </italic>
###xml 805 812 805 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola L </italic>
We also tested available mutations that affect individual lola isoforms. The orc4 (affecting isoform K; Figure 1b) allele did not show obvious defects (see additional files 1, 4 and 8). The ore119 allele (affecting isoform L; Figure 1b) shows a small subset of the phenotypes observed in lola-/- (see additional file 1). lola L-/- adPN targeting appears normal, but lPNs show a loss of targeting to VM1 and DA2, while ventral clones show a loss of DA1 targeting. However, we cannot rule out the possibility that an additional mutation on the lola L mutant chromosome contributes to the phenotype, as our attempts to generate a second allele specific for lola L have not been successful and the ore119 phenotype could not be rescued by a UAS-lola L transgene (data not shown). In fact, MARCM expression of lola L in PNs results in severe phenotypes by itself (see below).
###end p 25
###begin title 26
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
lola mutant projection neurons have axon wiring defects
###end title 26
###begin p 27
###xml 80 84 80 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 84 88 84 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 206 207 206 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 412 413 412 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 639 640 639 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
In addition to dendritic phenotypes, we observed defects in PN axonal wiring in lola-/- MARCM clones. As with dendrites, defects were found in adPNs, lPNs and vPNs as well as DL1 single-cell clones (Figure 3). Phenotypes were highly variable both in penetrance and severity in neuroblast as well as single cell clones. In a semi-quantitative approach, we scored phenotypes as mild, medium and severe (see Figure 3 legend). A separate quantification of the targeting defects limited by specific phenotypes (ectopic branching, misrouting of axons, SOG targeting and a lack of MB/LH innervation) is presented in Table S2 (see additional file 2).
###end p 27
###begin p 28
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 27 31 27 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 79 83 79 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 105 109 105 109 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 109 113 109 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 113 117 113 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 290 294 290 294 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 618 622 617 621 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d) </bold>
###xml 733 734 732 733 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 737 738 736 737 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 834 835 833 834 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 838 839 837 838 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
Axon wiring defects in lola-/- MARCM clones. Representative confocal images of (a) wild-type control and (b) lola-/- adNB (1), lNB (2) vNB (3) and DL1 SC (4) clones showing PN axons near their normal target: the mushroom body (MB) and lateral horn (LH), both marked by blue dotted circles. (c) Example of an axon mistargeting to SOG after exiting the posterior AL (blue dotted circle). Double-headed white arrow demarks dendritic mistargeting to SOG. Blue arrows denote a lack of correct targeting while yellow arrows demark ectopic branching. anti-CD8::GFP in green, anti-nc82 neuropil in magenta. Scale bar, 20 mum. (d) Quantification of severity of axon targeting defects. Mild: axons target correctly but have ectopic branches (b1, b2); medium: axons target to the correct region but follow an incorrect trajectory or bifurcate (b3, b4); severe: axons target to the SOG or abnormal brain regions (c).
###end p 28
###begin p 29
###xml 3 7 3 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 7 11 7 11 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 149 154 149 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b1,2</xref>
###xml 188 189 188 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 354 358 354 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 358 362 358 362 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3d</xref>
###xml 462 468 462 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ore5D2</italic>
###xml 552 553 552 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
In lola-/- adPNs and lPNs, the most common defect was ectopic branching outside of the region of the MB or the LH (28% and 63%, respectively; Figure 3b1,2; see Table S2 in additional file 2). Some clones showed a lack of innervation, where innervation of the MB failed to occur or branch extension in the LH was severely limited. A smaller percentage of lola-/- clones (15% adPNs and 7% PNs) showed medium or severe axon defects (Figure 3d). Hypomorphic clones (ore5D2) show similar, but mostly mild, targeting defects (see Table S2 in additional file 2).
###end p 29
###begin p 30
###xml 92 96 92 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 96 100 96 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 117 123 117 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ore5D2</italic>
###xml 141 146 141 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b3,d</xref>
###xml 187 188 187 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 275 279 275 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 279 283 279 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 641 644 641 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3a3</xref>
###xml 648 651 648 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b3</xref>
###xml 1063 1065 1063 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3c</xref>
Axons of vPNs are the most severely affected: nearly 100% of clones exhibit defects in both lola-/- and hypomorphic (ore5D2) alleles (Figure 3b3,d; see Table S2 and S4 in additional file 2). Often ventral axons show several defects in the same brain. Seventy-nine percent of lola-/- clones show ectopic branching defects (often extensions from the LH towards the SOG or an increase in branches along the medial extension). Thirty-four percent of clones show misrouting defects; most often a single axon defasciculates from the bundle and projects directly to the medial-central region of the LH instead of the ventral region (compare Figure 3a3 to 3b3). Nine percent of null clones and 47% of hypomorph clones show clear axonal targeting to the SOG (this may be higher in the null but it can be difficult to distinguish between axon and dendrite mistargeting unless clear defasciculation from the main axon bundle is visible). We observe that all PN axons exit the AL in a single bundle, but then some axons defasciculate and project ventrally to the SOG (Figure 3c). It is interesting to note that axons misguided to the SOG typically project to similar locations in the SOG, suggesting they may be responding to some cues in this region.
###end p 30
###begin p 31
###xml 66 71 66 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3b4,d</xref>
###xml 105 106 105 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 198 202 198 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 202 206 202 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 316 317 316 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 415 416 415 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 848 850 848 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 880 885 880 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
More than 50% of DL1 single cell clones show axon defects (Figure 3b4,d, see Table S3 in additional file 2), suggesting that Lola acts cell-autonomously in axon targeting. Twenty-six percent of DL1 lola-/- axons have ectopic branches, often with additional branches in the LH region (see Table S2 in additional file 2). Fifteen percent of clones fail to extend branches into the MB (see Table S2 in additional file 2). Some DL1 axons clearly bifurcate just prior to entering the MB. It is interesting to note that many DL1 clones that fail to target the DL1 glomerulus have relatively normal axonal projections. A severe dendrite phenotype does not predict the most severe axon phenotypes (or vice versa), suggesting that these two processes are separable, in agreement with recent observations of independence between axon and dendrite targeting [14]. These results suggest that lola has post-mitotic, cell-autonomous functions in PN axon targeting.
###end p 31
###begin title 32
###xml 12 17 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 39 47 39 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
Analysis of lola isoform expression by in situ hybridization and RT-PCR
###end title 32
###begin p 33
###xml 33 38 33 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 114 119 114 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 196 201 196 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 231 232 231 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 409 411 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 599 604 599 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
Our MARCM analysis suggests that lola has an important function for PN dendritic and axonal targeting. Given that lola encodes 20 alternatively spliced isoforms, several scenarios may account for lola function (see additional file 3). In scenario I, different isoforms may be expressed in different neuroblast lineages and thereby specify their lineage-specific wiring analogous to POU transcription factors [13]. In scenario II, individual PNs may express a unique isoform or combination of isoforms independent of lineage to specify PN identity. In scenario III, all cells may express most or all lola isoforms.
###end p 33
###begin p 34
###xml 61 69 61 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 116 121 116 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 239 240 239 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 265 273 265 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 306 314 306 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">drifter </italic>
###xml 315 318 315 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dfr</italic>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 479 483 479 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dfr </italic>
###xml 583 584 583 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 695 696 695 696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 717 725 717 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 739 744 739 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 767 772 767 772 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 832 838 832 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a1,a3</xref>
###xml 876 879 876 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4a2</xref>
###xml 1013 1018 1013 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 1158 1159 1158 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 1175 1181 1175 1181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4d1,d3</xref>
###xml 1369 1370 1369 1370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1392 1393 1392 1393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 1519 1520 1519 1520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
###xml 1718 1725 1718 1725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nerfin </italic>
###xml 1726 1728 1726 1728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1793 1798 1793 1798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 1912 1917 1912 1917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 2016 2017 2016 2017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S3">3</xref>
To distinguish between these possibilities, we performed RNA in situ hybridization with probes against 16 of the 20 lola isoforms at 0 h after puparium formation (APF), a developmental time when PNs start to elaborate dendrites in the AL [4]. We first verified our in situ protocol by using probes against drifter (dfr), a TF that has previously been shown to be expressed in GH146 labeled lPNs but not adPNs [13]. As expected, we found that signal from anti-sense probe against dfr mRNA coincides with green fluorescent protein (GFP)-labeled lPNs but not adPNs (see additional file 3). A sense control probe shows little signal coinciding with the GFP-positive cell bodies (see additional file 3). We then performed in situ analysis with lola probes. A probe to the lola common region shows expression throughout the brain (Figure 4a1,a3) compared with sense control (Figure 4a2), consistent with our Lola antibody staining results. For individual isoform mRNAs, we detect signal in the region of the AL for all lola isoforms tested, as well as other brain regions. Some isoforms have narrower domains of expression, such as isoforms N (see additional file 3) and T (Figure 4d1,d3), which have much stronger signal in the central brain and weaker staining in the optic lobe. Other isoforms appear to be expressed more uniformly throughout the region of the AL (Figure 4; see additional file 3). It should be noted that several isoforms have more punctate signal that co-localizes with the nucleus (see additional file 3f, k, r), perhaps indicative of pre-mRNA. Another caveat is that mRNA production may not translate to protein expression, as recently shown by the wide mRNA but narrow protein expression domains of nerfin [31]. We did not find PN lineage-specific expression for any of the lola isoforms, nor is there evidence that any isoforms are expressed in a subset of PNs within a lineage. Rather, most lola isoform mRNAs appear to be expressed in all PNs, consistent with scenario III (see additional file 3).
###end p 34
###begin p 35
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 35 46 35 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 53 59 53 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a-d) </bold>
###xml 63 71 63 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 83 88 83 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 100 101 100 101 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 161 166 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 218 219 218 219 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 289 290 289 290 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 327 332 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 737 738 737 738 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 740 741 740 741 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 834 835 834 835 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 837 838 837 838 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 919 920 918 919 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 922 923 921 922 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 936 937 934 935 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 939 940 937 938 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1021 1022 1019 1020 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1027 1035 1025 1033 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 1058 1063 1056 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 1119 1123 1117 1121 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(e) </bold>
###xml 1190 1198 1188 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 1271 1276 1269 1274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 1430 1435 1428 1433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 1579 1587 1577 1585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">actin42 </italic>
Expression of lola isoforms in the Drosophila brain. (a-d) RNA in situ analysis of lola isoforms. (a1) An antisense probe generated against the common region of lola labels uniformly throughout the brain at 0 h APF. (a2) A sense control to the same probe shows little specific staining. (a3) A magnified view of the AL reveals lola expression in all PN cell bodies. PN cell bodies are marked by white arrows, while dotted while lines demark the rough area of the AL neuropil in each section that is not stained by DAPI. Midline to the left, lateral to the right. Isoform specific probes to isoform L (b), isoform Q (c) and isoform T (d) show different patterns of expression throughout the brain at 0 h APF, while sense control probes (b2-d2) show little specific labeling. Closer inspection of AL regions at a higher magnification (b3-d3) reveals that most isoforms appear to be expressed in PNs. Scale bars: 20 mum (a3-d3); 200 mum (a1-d2). DIG-labeled RNA probe in red, DAPI in blue, GFP in green. See Additional file 2 for in situ analysis of additional lola isoforms and additional labeling of section morphology. (e) Quantitative RT-PCR of laser-captured PN enriched-samples verifies in situ results that most isoforms are expressed in PNs. Additionally, different lola isoforms are expressed at different levels at 0 h APF, with about 100-fold difference between highest and lowest expression levels. Data are displayed by lola isoform on the X-axis and by relative abundance on a log scale on the Y-axis, where relative abundance has been determined against the level of actin42 expression. Error bars represent the standard deviation from four independent samples, and each sample was tested independently five times per device. Horizontal solid line represents a confidence limit of the average relative expression of samples near the detection limit based on CT values and reproducibility.
###end p 35
###begin p 36
###xml 455 463 455 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 511 516 511 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4e</xref>
###xml 735 737 735 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4e</xref>
###xml 910 915 910 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 1026 1027 1026 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 1034 1042 1034 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 1070 1075 1070 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 1224 1229 1224 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 1389 1390 1389 1390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S4">4</xref>
###xml 1451 1456 1451 1456 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
As an independent and more quantitative method of assessing expression of different isoforms in PNs, we performed laser-dissection microscopy (LCM) to capture GH146-positive PNs from frozen sections of 0 h APF tissue, followed by quantitative RT-PCR to detect the expression level of individual isoforms. Although we do not have single-cell resolution, laser-dissection allows us to assay mRNA expression in a small subset of neurons. Consistent with the in situ hybridization data, at 0 h APF we detected most lola isoforms by RT-PCR, although several isoforms are near the RT-PCR detection limit (Figure 4e). We find marked differences (up to 100-fold) in the level of RNA expression of individual isoforms in PNs at 0 h APF (Figure 4e). We additionally analyzed AL samples from different developmental timepoints (third instar larvae, 0 h APF, 25 h APF and adult) and find that expression levels of several lola isoforms, for example isoform E, H, I, L, M and Q, appear to be developmentally regulated (see additional file 4). Our in situ results also suggested that lola isoforms are expressed at different levels in the optic lobe. Indeed, RT-PCR on LCM captured optic lobe at 0 h APF confirmed that mRNAs of different lola isoforms are expressed at different levels and revealed differences in the pattern of isoform expression between AL and optic lobe samples (see additional file 4). Together, these data suggest that the level of individual lola isoform expression is dynamically regulated and that individual isoforms may function at different stages in development.
###end p 36
###begin title 37
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola </italic>
UAS-lola transgene overexpression phenotypes
###end title 37
###begin p 38
###xml 79 80 79 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">1</xref>
###xml 311 316 311 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 406 413 406 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola A </italic>
###xml 417 424 417 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola T </italic>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 484 494 484 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola L</italic>
###xml 717 718 717 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 740 741 740 741 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 788 798 788 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola A</italic>
###xml 800 811 800 811 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola L </italic>
###xml 815 825 815 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola T</italic>
###xml 873 874 873 874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1169 1174 1169 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
Genetic analysis using available isoform-specific alleles (see additional file 1) indicates that at least two isoforms (K and L) are not required for dendritic targeting of the majority of PN classes. To test further potential functions of different isoforms, we examined the overexpression phenotypes of three lola isoforms. Previous reports suggested differences between the overexpression phenotypes of lola A and lola T in motor neurons [25]. We have generated a third transgene, UAS-lola L. We found that Gal4-GH146 expression of any of these three UAS transgenes results in lethality, but we bypassed this lethality by MARCM mediated transgene expression in specific neuroblast lineages or single cells (Figure 5; see additional file 5). We tested one, three and two insertions for UAS-lola A, UAS-lola L and UAS-lola T, respectively (see Table S1 in additional file 2). Levels of transgene expression were verified in our attempted rescue experiments (see below). Because Gal4-GH146 drives transgene expression in post-mitotic PNs (J Liu, MS, LL, unpublished observation), the overexpression phenotypes we describe below are caused by post-mitotic expression of lola transgenes.
###end p 38
###begin p 39
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 120 124 120 124 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 136 142 136 142 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b-f) </bold>
###xml 223 234 223 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola A </italic>
###xml 283 294 283 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola L </italic>
###xml 306 313 306 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola T </italic>
###xml 374 381 374 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola T </italic>
###xml 624 628 623 627 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(g) </bold>
###xml 773 784 772 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola T </italic>
###xml 911 918 898 905 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(h, i) </bold>
Effects of overexpressing different lola isoforms on dendritic and axonal phenotypes. Representative confocal images of (a) control and (b-f) Gal4-GH146 MARCM overexpression phenotypes in vNB (1), DL1 (2) and DL1 axon (3). UAS-lola A (b) overexpression shows little defects, whereas UAS-lola L (c) and UAS-lola T (d-f) show defects in most classes of PNs. The effect of UAS-lola T (d-f) expression increases with increasing temperature. anti-CD8::GFP in green, anti-nc82 neuropil in magenta. Scale bar, 20 mum. Blue circles demark a loss of correct targeting, while yellow arrows demark off-target innervation or branching. (g) Quantification of vNB targeting phenotypes. Data are presented as percentage of observed clones that innervate a given target. Overexpression of UAS-lola T at 25degreesC or 29degreesC results in a decrease in DA1 targeting and an increase in ectopic dendritic extensions to the SOG. (h, i) Quantification of DL1 phenotypes. Dendrite defects are quantified (h) by percent of clones that fail to target DL1 and those that target DL1 but have additional dendrite extensions and ectopic innervations in the AL. Axon defects (i) are quantified as in Figure 3.
###end p 39
###begin p 40
###xml 48 59 48 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola A </italic>
###xml 127 129 127 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5b</xref>
###xml 151 152 151 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 164 175 164 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola L </italic>
###xml 179 190 179 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola T </italic>
###xml 208 209 208 209 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 213 214 213 214 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 215 216 215 216 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 319 320 319 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 736 737 736 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S5">5</xref>
###xml 747 758 747 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola T </italic>
Neuroblast or single cell clones overexpressing UAS-lola A (which lacks a Zn-finger) do not exhibit detectable defects (Figure 5b; see additional file 5). However, UAS-lola L and UAS-lola T (which both have C2HC-C2H2-type Zn-fingers) show strong targeting defects in adPN and lPN neuroblast clones (see additional file 5). Phenotypes often include a large increase in wandering dendrites in the AL and some degree of loss of targeting and ectopic targeting. Often dendrites appear to be largely restricted to one region of the AL such as dorsal or lateral, and have wandering dendrites through this region in many glomeruli, but fail to innervate normal targets or extend any dendrites into other regions of the AL (see Additional file 5c, e, f). UAS-lola T expression also results in a decrease in the number of labeled PNs, in part likely due to cytotoxicity based on the observation of clones with very punctate GFP staining patterns indicative of cell and process degeneration, although we were unable to reliably stain brain tissues for activated caspase-3 (V Trunova and E Giniger, unpublished data). Due to the difficulty in quantifying phenotypes in adPN and lPN neuroblast clones because of the magnitude and variability, we focused our analysis on vPN neuroblast clones and single-cell DL1 clones.
###end p 40
###begin p 41
###xml 90 97 84 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola A </italic>
###xml 105 108 99 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5b1</xref>
###xml 150 157 144 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola L </italic>
###xml 165 168 159 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5c1</xref>
###xml 205 212 199 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola T </italic>
###xml 235 241 229 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5e1,f1</xref>
###xml 304 311 298 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola T </italic>
###xml 319 327 313 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5e1,f1,g</xref>
vPN neuroblast clones in animals raised at 25degreesC show no defects when overexpressing lola A (Figure 5b1) and weak phenotypes when overexpressing lola L (Figure 5c1), but vPNs are strongly affected by lola T overexpression (Figure 5e1,f1). Targeting to DA1 is often lost in vPN clones overexpressing lola T (Figure 5e1,f1,g). vPN dendrites frequently extend outside of the AL boundary, most often in the ventral region projecting towards the SOG. Processes of the pan-AL vPN are not elaborated properly and only partially innervate the AL.
###end p 41
###begin p 42
###xml 123 130 123 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola A </italic>
###xml 211 217 211 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5b2,b3</xref>
###xml 262 269 262 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola L </italic>
###xml 394 399 394 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5c2,h</xref>
###xml 430 437 430 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola L </italic>
###xml 509 514 509 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5c3,i</xref>
###xml 675 682 675 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola T </italic>
###xml 911 919 911 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5e2,f2,h</xref>
###xml 922 929 922 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola T </italic>
###xml 1097 1105 1097 1105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5e3,f3,i</xref>
###xml 1278 1280 1278 1280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4e</xref>
DL1 single-cell clones were used to examine cell-autonomous overexpression effects on both dendritic and axonal targeting. lola A overexpression did not affect targeting of either DL1 axons or dendrites (Figure 5b2,b3). The DL1 dendrites targeted correctly with lola L overexpression, but frequently showed a large increase in dendritic mass outside of DL1, wandering throughout the AL (Figure 5c2,h). In axons, overexpression of lola L often resulted in an increase in branching in MB and LH regions (Figure 5c3,i). In the LH, these additional branches resulted in a loss of the stereotypic 'L' projection and a failure of branches to fully extend into normal target areas. lola T overexpression resulted in variable DL1 phenotypes, ranging from a complete loss of DL1 innervation and targeting to other regions of the AL to DL1 targeting with dendritic extensions outside of the DL1 glomerular region (Figure 5e2,f2,h). lola T overexpression also affected axon targeting, most often resulting in a high degree of ectopic branching, axon bifurcation and incorrect LH innervation patterns (Figure 5e3,f3,i). It is interesting to note that isoforms L and T are normally expressed at low levels based on RT-PCR results, while isoform A is expressed roughly 10-fold higher (Figure 4e). Differences in overexpression phenotype may be related to the presence or absence of a Zn-finger domain, and/or to the expression level relative to the endogenous level of expression.
###end p 42
###begin title 43
###xml 0 11 0 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola T </italic>
UAS-lola T dosage sensitivity
###end title 43
###begin p 44
###xml 81 91 81 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola T</italic>
###xml 364 375 364 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola T </italic>
###xml 710 716 692 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5d,e,f</xref>
###xml 803 805 785 787 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5h</xref>
###xml 1011 1015 975 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5h,i</xref>
###xml 1049 1050 1013 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 1145 1147 1109 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5g</xref>
###xml 1255 1260 1219 1224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
In the course of our overexpression study, we tested two different insertions of UAS-lola T. We noticed that the insertion on the third chromosome gives stronger and more penetrant phenotypes than the insertion on the X chromosome, and hypothesized that this was due to differences in transgene expression levels. To test this hypothesis, we altered the levels of UAS-lola T (X insertion) transgene expression by raising animals at 18degreesC, 25degreesC or 29degreesC, as levels of Gal4-induced transgene expression increase with increasing temperatures. In neuroblast clones we observed a qualitative increase of phenotypic severity in both dendritic and axonal targeting with increasing temperature (Figure 5d,e,f). This dosage sensitivity can be quantified with the DL1 dendritic phenotypes (Figure 5h). Flies raised at 18degreesC have few dendritic phenotypes, while at 25degreesC and 29degreesC dendrites mistarget and have ectopic innervations and axons have additional branches and bifurcations (Figure 5h,i; see Table S1 in additional file 2). Additionally, dosage sensitivity is evident in vNB DA1 and SOG extension phenotypes (Figure 5g). This experiment indicates that PN dendritic targeting is sensitive to the expression level of a specific lola isoform.
###end p 44
###begin title 45
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
Individual lola isoform expression in a lola null background
###end title 45
###begin p 46
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 62 66 62 66 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 139 143 139 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 143 147 143 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 166 176 166 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola A</italic>
###xml 178 189 178 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola L </italic>
###xml 192 203 192 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola T </italic>
###xml 323 327 323 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 327 331 327 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 540 544 540 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 544 548 544 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 639 640 639 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6</xref>
###xml 662 663 662 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S6">6</xref>
###xml 733 738 733 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 911 912 911 912 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S6">6</xref>
To test if individual lola isoforms can rescue any of the lola-/- phenotype, we performed MARCM analysis on clones that are simultaneously lola-/- and express either UAS-lola A, UAS-lola L or UAS-lola T transgenes. We verified all transgenes are expressed based on the presence of Lola antibody staining in these otherwise lola-/- clones. Expression of all transgenes was qualitatively similar at a level roughly half as intense as neighboring non-mutant cells expressing endogenous levels of Lola (data not shown). Instead of rescuing the lola-/- phenotype, overexpression of transgenes in mutant PNs resulted in additive defects (Figure 6; see additional file 6). In adPN and lPN neuroblast clones, simultaneous loss of endogenous lola and expression of any of the single isoforms caused striking additive effects in cell loss and lack of dendritic extension, which are described in detail in additional file 6. Below we focus on vPN neuroblast clones and DL1 single cell clones.
###end p 46
###begin p 47
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 36 40 36 40 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 138 142 138 142 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 154 160 154 160 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b-e) </bold>
###xml 270 281 270 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola A </italic>
###xml 286 297 286 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola L </italic>
###xml 305 316 305 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola T </italic>
###xml 334 338 334 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 338 342 338 342 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 402 406 402 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 406 410 406 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 442 453 442 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola A </italic>
###xml 457 468 457 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola T </italic>
###xml 519 523 519 523 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(f) </bold>
###xml 645 654 645 654 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola </italic>
###xml 684 688 684 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 688 692 688 692 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 855 866 855 866 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola A </italic>
###xml 870 880 870 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola T</italic>
###xml 990 994 990 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 994 998 994 998 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1010 1014 1010 1014 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(g) </bold>
###xml 1072 1075 1072 1075 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS</italic>
###xml 1076 1083 1076 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola L </italic>
###xml 1087 1098 1087 1098 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola T </italic>
###xml 1138 1142 1138 1142 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(h) </bold>
###xml 1198 1209 1198 1209 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola L </italic>
###xml 1213 1224 1213 1224 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola T </italic>
###xml 1271 1275 1271 1275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 1275 1279 1275 1279 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
UAS-transgene overexpression in lola-/- MARCM clones results in additive dendritic and axonal targeting defects. Representative images of (a) control and (b-e) experimental conditions as indicated for the vNB (1), DL1 single-cell dendrite (2) and axon (3) phenotypes of UAS-lola A (c), UAS-lola L (d) and UAS-lola T (e) expression in lola-/- MARCM clones. None of the transgenes are able to rescue the lola-/- phenotype. Expression of either UAS-lola A and UAS-lola T both result in a decrease in dendrite elaboration. (f) Quantification of vNB phenotypes. Data are presented as percentage of observed clones that innervate a particular target. UAS-lola transgenes fail to rescue the lola-/- phenotype. Often transgene expression has an additive effect and further disrupts normal targeting, for example, there are dramatic losses of VA1lm targeting with UAS-lola A and UAS-lola T. 'N' for rescue experiments are low due to extreme difficulty in generating MARCM UAS-expression clones in a lola-/- background. (g) Quantification of DL1 dendrite phenotypes as in Figure 5. UAS-lola L and UAS-lola T clones lack normal dendritic targeting. (h) Quantification of DL1 axonal phenotypes as in Figure 2. UAS-lola L and UAS-lola T show increases in axonal defects compared with lola-/- alone. anti-CD8::GFP in green, anti-nc82 neuropil in magenta. Scale bar, 20 mum.
###end p 47
###begin p 48
###xml 69 73 69 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 73 77 73 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 93 103 93 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola A</italic>
###xml 105 116 105 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola L </italic>
###xml 119 130 119 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola T </italic>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6f</xref>
###xml 464 468 464 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 468 472 468 472 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 495 500 495 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 586 591 586 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 689 694 689 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
Additive effects of transgene expression were most striking in vPNs. lola-/- vPNs expressing UAS-lola A, UAS-lola L or UAS-lola T resulted in strong reduction of VA1lm and DA1 targeting (Figure 6f). Additionally, the pan-AL neuron often showed little dendritic process elaboration and rarely innervated much of the AL. Dendrites and axons of ventral cells often looked punctate, indicative of degeneration. These data indicate that expression of UAS transgenes in lola-/- clones fails to rescue lola phenotypes and further disrupts dendritic wiring. Additionally, expression of certain lola isoforms alone may be toxic, perhaps due to dominant-negative interactions with other proteins or lola dimerization.
###end p 48
###begin p 49
###xml 44 47 44 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS</italic>
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 77 81 77 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 81 85 81 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 400 404 400 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 404 408 404 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 425 435 425 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola T</italic>
###xml 541 545 541 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6e,g</xref>
###xml 548 552 548 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 552 556 552 556 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 573 584 573 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola L </italic>
###xml 682 686 682 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 686 690 686 690 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 707 718 707 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola A </italic>
###xml 768 774 768 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6c,d,g</xref>
###xml 781 785 781 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 785 789 785 789 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 808 817 808 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola </italic>
###xml 959 961 959 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6h</xref>
###xml 1005 1010 1005 1010 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 1217 1222 1217 1222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 1243 1249 1243 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola T</italic>
DL1 clones were difficult to obtain for all UAS-lola transgenes expressed in lola-/- clones, possibly due to toxicity that we observe in neuroblast clones. Phenotypes did not always appear additive for DL1 clones, perhaps due to low levels of MARCM-based expression in single cell clones during the critical time of dendritic and axonal targeting. The strongest dendritic phenotypes were observed in lola-/- cells expressing UAS-lola T, where every clone either failed to innervate DL1 or had extensions into other regions of the AL (Figure 6e,g). lola-/- cells expressing UAS-lola L innervated DL1 in addition to having extensive dendritic innervation in the rest of the AL, while lola-/- cells expressing UAS-lola A were variable, with half appearing normal (Figure 6c,d,g). All lola-/- cells expressing a UAS-lola transgene showed axonal defects, ranging from a failure to extend or elaborate branches in the LH to an increase in ectopic branching (Figure 6h). These phenotypes suggest that individual lola isoforms can function post-mitotically to disrupt dendrite and axon targeting in DL1, and suggest that Lola interacts either as homomers or with other BTB domain proteins. Additionally, expression of single lola isoforms, especially lola T, appears to be toxic to many cells, so it is unclear if phenotypes are directly related to targeting or perhaps secondary effects due to disruption of cell viability.
###end p 49
###begin p 50
###xml 68 73 68 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 169 174 169 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 245 249 245 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
Taken together, these results suggest that isoform diversity of the lola locus is important. Post-mitotic expression of a single isoform is not sufficient to rescue the lola phenotype, and indeed is more disruptive to a cell than simple loss of lola. This does not, however, rule out an additional function of Lola in the neuroblast. Lastly, some aspects of Lola function are likely mediated through the BTB domain alone, as additive phenotypes can be caused by expressing isoforms with or without Zn-fingers.
###end p 50
###begin title 51
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
Evidence that lola regulates cell identity and transcription
###end title 51
###begin p 52
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 388 392 388 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 392 395 392 395 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
The dendritic and axonal phenotypes in lola-/-clones we described so far could be caused by the action of Lola on PN targeting directly (for instance, by regulating the expression of cell surface receptors), or Lola could regulate PN identity with axonal and dendritic mistargeting as a secondary consequence. Although these models are not mutually exclusive, we provide some evidence in lola-/-MARCM clones using several Gal4 lines, including Mz19, GH146 and NP3529, to support the second hypothesis.
###end p 52
###begin p 53
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 107 111 107 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 111 114 111 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ore</italic>
###xml 115 116 115 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 111 118 111 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ore</italic>5<italic>D</italic>2 </sup>
###xml 119 124 119 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 139 143 139 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 143 147 143 147 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 241 247 241 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7a2,a3</xref>
###xml 270 276 270 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2a5,a6</xref>
###xml 336 342 336 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola L</italic>
###xml 342 345 342 345 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 346 350 346 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 350 353 350 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ore</italic>
###xml 350 356 350 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ore</italic>119</sup>
###xml 410 413 410 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7a5</xref>
###xml 665 666 665 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 766 771 766 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 846 851 846 851 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 900 904 900 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 904 908 904 908 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 912 918 912 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola L</italic>
###xml 918 921 918 921 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 1123 1129 1123 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7a4,a6</xref>
###xml 1203 1208 1203 1208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 1230 1234 1230 1234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 1234 1241 1234 1241 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ore119 </sup>
MARCM with several mutant alleles suggests that lola regulates the expression of Gal4-Mz19. Ten percent of lolaore5D2 (lola hypomorph) and lola-/- clones show a 30% to 50% increase in the number of labeled PNs and targeted glomeruli (Figure 7a2,a3; MARCM control Figure 2a5,a6). Strikingly, we observed (in 64% of all adPN clones) that lola L-/-(lolaore119) clones frequently target the DL1 glomerulus (Figure 7a5), which is normally targeted by GH146 positive, but never Mz19 positive, PNs. As our heat-shock timing in these experiments should not result in any Mz19 single cell clones (they are born later) but coincides exclusively with the birth of the DL1 PN [2], the simplest interpretation is that Mz19 is now misexpressed in DL1 PNs. This would suggest that lola normally represses Mz19 expression in DL1 PNs. As additional evidence that lola regulates gene expression, 25% of clones of both lola-/- and lola L-/-visualized by Gal4-Mz19 appear to label local interneurons (LNs), an additional cell-type that innervates a large number of glomeruli in the AL and lacks axonal projections out of the AL region (Figure 7a4,a6). The similarity of isoform L specific phenotypes to phenotypes in other lola alleles suggests that lolaore119 phenotypes in PNs might be caused by the disruption in isoform L instead of a second site mutation on the same chromosomal arm. Thus, it appears that in the absence of Lola (particularly the Lola L isoform), Gal4-Mz19 is ectopically expressed in neuronal types that normally do not express this Gal4 enhancer trap line.
###end p 53
###begin p 54
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 66 70 66 70 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(a) </bold>
###xml 126 139 126 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-GFP::CD8 </italic>
###xml 181 182 181 182 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 246 251 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 337 338 337 338 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 341 342 341 342 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 426 427 426 427 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 430 431 430 431 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 500 501 500 501 <sub xmlns:xlink="http://www.w3.org/1999/xlink">5</sub>
###xml 504 508 504 508 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(b) </bold>
###xml 508 512 508 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 512 516 512 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 670 674 670 674 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(c) </bold>
###xml 754 755 754 755 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 758 762 758 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 762 766 762 766 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 885 886 885 886 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 889 894 889 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lolaL</italic>
###xml 894 898 894 898 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 932 933 932 933 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 991 998 991 998 <bold xmlns:xlink="http://www.w3.org/1999/xlink">(d, e) </bold>
###xml 998 1003 998 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 1147 1151 1147 1151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 1151 1155 1151 1155 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1213 1217 1213 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 1217 1220 1217 1220 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
Evidence that lola regulates expression of Gal4 drivers and Lim1. (a) Gal4-Mz19 mislabeling analysis. Whole-animal Gal4-Mz19, UAS-GFP::CD8 expression labels a small subset of PNs (a1). See Figure 2 for Mz19 and GH146 MARCM controls. Mutations in lola result in the labeling of more cell bodies than Mz19 normally labels (hypo: ore5D2) (a2, a3), as well as the labeling of ectopic cell types such as local interneurons (LNs) (a4, a6) and DL1 that is normally labeled by Gal4-GH146 but not Gal4-Mz19 (a5). (b) lola-/- Gal4-GH146 clones frequently mislabel a set of neurons in the region of the AL that project to the medial lobe of the MB and to the central body complex. (c) NP3529 mislabeling analysis. NP3529 labels two dorsal PNs that project to DL1 (c1). lola-/- clones dramatically increase the number of cells labeled near the AL, including cells in the lateral lineage and LNs (c2). lolaL-/- clones show similar mislabeling (c3). anti-CD8::GFP in green, anti-nc82 neuropil in magenta. (d, e) lola regulates Lim1 expression in vPNs. Wild-type cells in the region of the antennal lobe, including most (at least four) vPNs express Lim1 (d). In lola-/- cells, Lim1 expression is lost in vPNs (e). Note that the lola-/-clone includes neighboring cells in addition to those labeled by Gal4-GH146, and many cells have lost Lim1 staining. White arrows mark the cell bodies of GFP positive cells. anti-CD8::GFP in green, anti-Lim1 in magenta, DAPI in blue. Scale bar, 10 mum.
###end p 54
###begin p 55
###xml 134 137 134 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7b1</xref>
###xml 161 166 161 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2a1&#8211;3</xref>
###xml 181 185 181 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 185 189 185 189 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 389 394 389 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7b2&#8211;3</xref>
###xml 493 497 493 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 497 501 497 501 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 546 547 546 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 704 708 704 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 708 712 708 712 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 798 802 798 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
Gal4-GH146, used extensively in this study, labels a large subset of PNs in the AL, roughly 50 adPNs, 35 lPNs and 5 or 6 vPNs (Figure 7b1; MARCM controls Figure 2a1-3). However, in lola-/- neuroblast clones we observe labeling of a new cell type that innervates a small region of the AL and sends projections to the medial axonal lobe of the MB as well as the central body complex (Figure 7b2-3). These cells are never labeled in control experiments, but make up 22% of all observed clones in lola-/- experiments (see Table S5 in additional file 2). Interestingly, we observe similar projection patterns in wild-type neurons labeled with other Gal4 drivers, suggesting that central body complex targeted lola-/- clones are a different cell type where Gal4-GH146 expression is normally repressed by lola.
###end p 55
###begin p 56
###xml 62 65 62 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7c1</xref>
###xml 95 99 95 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 99 103 99 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 107 113 107 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola L</italic>
###xml 113 117 113 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 294 298 294 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 298 302 298 302 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 389 392 389 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7c2</xref>
###xml 395 401 395 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola L</italic>
###xml 401 405 401 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 454 457 454 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7c3</xref>
###xml 488 493 488 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
Gal4-NP3529 labels two dorsal PNs that project to DL1 (Figure 7c1). Clones generated with both lola-/- and lola L-/- label much larger subsets of cells. These clones often contain PNs that innervate typical GH146 target glomeruli, as well as LNs and other PN classes that do not express GH146. lola-/- clones label many additional cells in the adPN lineage as well as lPNs and LNs (Figure 7c2). lola L-/- clones show similar types of mislabeling (Figure 7c3). This strongly suggests that lola function is normally necessary to repress the expression of NP3529 in multiple cell types.
###end p 56
###begin p 57
###xml 157 163 157 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7d1,d2</xref>
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 174 178 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 178 182 178 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 228 234 228 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F7">7e1,e2</xref>
###xml 295 306 295 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola A </italic>
###xml 309 320 309 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola T </italic>
###xml 323 327 323 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 327 331 327 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 354 365 354 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola A </italic>
###xml 369 379 369 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola T</italic>
###xml 453 457 453 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cut </italic>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 505 509 505 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 509 512 509 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 558 561 558 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cut</italic>
###xml 561 564 561 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 704 708 704 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 710 715 710 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lim1 </italic>
###xml 718 722 718 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cut </italic>
###xml 762 766 762 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cut </italic>
###xml 770 775 770 775 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 945 949 945 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink">acj6</italic>
###xml 951 958 951 958 <italic xmlns:xlink="http://www.w3.org/1999/xlink">drifter</italic>
###xml 960 963 960 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cut</italic>
###xml 965 970 965 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink">chip </italic>
###xml 974 979 974 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">islet</italic>
###xml 1002 1006 1002 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 1006 1010 1006 1010 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1075 1080 1075 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
Lola also appears to positively regulate gene expression. Lim1 is expressed in a subset of PNs, including most (at least four) vPNs labeled by GH146 (Figure 7d1,d2) [14]. In lola-/- mutant cells, Lim1 expression is lost (Figure 7e1,e2). Lim1 expression cannot be rescued by expression of either UAS-lola A or UAS-lola T in lola-/- clones (n = 2 each for UAS-lola A and UAS-lola T; data not shown). Lim1 expression is also lost in vPNs mutant for the TF cut [14]. However, Cut expression is not altered in lola-/-clones, and Lola expression is not altered in cut-/-clones (data not shown), suggesting these TFs coordinately regulate Lim1 expression through parallel pathways. Intriguingly, PNs mutant for lola, lim1 or cut all fail to target DA1, suggesting that cut and lola may be necessary for regulation of other TFs as well as wiring. Antibody staining patterns of other TFs previously identified to be important for PN targeting, including acj6, drifter, cut, chip and islet, are not disrupted in lola-/- clones (data not shown). Taken together, these data suggest that lola can positively and negatively regulate gene expression of other genes known to label subsets of PNs or to play a role in PN wiring specificity.
###end p 57
###begin title 58
Conclusion
###end title 58
###begin p 59
###xml 22 33 22 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 230 234 230 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 234 238 234 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 554 559 554 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 673 678 673 678 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lim1 </italic>
###xml 711 716 711 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 941 946 941 946 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 1128 1133 1128 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">chip </italic>
###xml 1134 1136 1134 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1260 1265 1260 1265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
Wiring specificity in Drosophila olfactory projection neurons is regulated by intrinsic TFs [13-15]. Here we have characterized an additional TF, Lola, as necessary for proper AL wiring specificity of both PN dendrites and axons. lola-/- mutant clones show a wide variety of wiring phenotypes, including a loss of targeting to correct glomeruli, innervation of ectopic targets, a loss of lineage restriction in dendritic projections, a loss of AL boundary restriction, and an increase in wandering projections and ectopic branch formation. Additionally, lola appears normally to repress the expression of multiple Gal4 drivers in certain cell-types and positively regulate lim1 in vPNs. These data suggest that lola regulates multiple developmental processes, including identity as well as wiring specificity of PNs, consistent with its expression in neuroblasts and post-mitotic neurons. In fact, the wide variety of phenotypes observed in lola mutants may be a general characteristic of genes involved in multiple developmental processes, as similar phenotypes are observed in mutants of general TF complex cofactors, such as chip [14], or are known chromatin regulatory genes (D Berdnik and LL, unpublished data). This is the first report linking roles for lola in both fate and wiring specificity in the same cell-type, suggesting that PNs have a tightly linked relationship between targeting specificity and cell identity.
###end p 59
###begin p 60
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 253 258 253 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 334 337 334 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS</italic>
###xml 338 343 338 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 476 481 476 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 527 532 527 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 865 870 865 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 936 938 936 938 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 939 941 939 941 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 942 944 942 944 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 945 947 945 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
lola is a highly complex genetic locus and encodes at least 20 different splice isoforms [16]. Although Lola is expressed throughout development, quantitative RT-PCR reveals that individual isoforms have different levels of expression. The diversity of lola isoform expression in PNs also appears important, as expression of a single UAS-lola transgene fails to rescue null mutant phenotypes and often results in even more severe phenotypes that are specific to the expressed lola isoform. We tested available isoform-specific lola alleles, and found that an isoform L (but not K) mutant has mild targeting defects. The difficulties of generating other isoform-specific alleles in this locus, coupled with the strong gain-of-function effect of expressing transgenes of a single isoform, made it difficult for us to investigate further isoform-specific functions of lola in PN development. However, taken together with previous reports [16,25,16,25], our results support the notion that different isoforms may have unique functions in PNs in addition to embryonic motor neurons.
###end p 60
###begin p 61
###xml 114 119 114 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 260 262 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 402 403 402 403 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 426 428 426 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 630 636 630 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">copia </italic>
###xml 653 655 653 655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 944 945 944 945 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 1065 1078 1065 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink">polyhomeotic </italic>
###xml 1124 1128 1124 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Hox </italic>
###xml 1305 1307 1305 1307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1337 1342 1337 1342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 1376 1381 1376 1381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
Several lines of evidence suggest that Lola can regulate chromatin structure. Loss of function (LOF) mutations in lola enhance the Pc/+ phenotype and result in a significant increase in the number of sex-combs on the second leg, as do other known PcG factors [28]. This reported PcG interaction, in addition to direct binding of the chromosomal kinase JIL-1 and the presence of the nucleosome binding C2HC class Zn-finger [20,21], suggests that at least some Lola isoforms may be part of chromatin regulatory complexes. Additionally, at least one Lola isoform has been shown to bind directly to DNA and regulate expression of the copia retrotransposon [22]. Many chromatin regulators are integral components in pathways of cell fate specification. Neuronal cell fate is closely linked with dendritic and axonal targeting, particularly in PNs where cell identities based on birth order are manifested as wiring choices and target specification [2]. This link between targeting and cell identity has been suggested in the MB, where mutation of the chromatin modifier polyhomeotic causes MB neurons to randomly express certain Hox genes that are normally suppressed and to display a wide variety of axon targeting defects that are neither a complete targeting fate switch nor consistent between individuals [32]. This is reminiscent of the lola phenotype in PNs, suggesting that lola might function in a similar manner.
###end p 61
###begin p 62
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 60 65 60 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 269 274 269 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 298 303 298 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 415 420 415 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 473 474 473 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 488 490 488 490 <sub xmlns:xlink="http://www.w3.org/1999/xlink">b </sub>
###xml 575 577 575 577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 578 580 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 584 586 584 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 633 638 633 638 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 1196 1201 1196 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 1283 1288 1283 1288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
lola may additionally play a more direct role in targeting. lola mutants affect some glomeruli more severely than others and have post-mitotic functions in DL1 dendritic targeting, suggesting that there is a differential requirement for, or sensitivity to, the loss of lola between individual PNs. lola also has specific targeting phenotypes in the embryonic central and peripheral nervous systems, as mutations in lola seem to disrupt axon guidance and extension of the Ap+, VUM, and ISNb neurons without affecting the numbers or differentiation of these neuronal subtypes [16,24,25,29]. Taken together, this evidence suggests that lola may participate both in fate determination and, more directly, in wiring specificity. If the processes of fate determination and wiring specificity are separable, one might expect a factor that controls wiring to directly regulate the expression of genes that function in targeting, such as cell surface receptors, while a factor that controls cell fate should affect the expression of 'fate' markers that subsequently disrupt downstream expression of the components of the wiring machinery in an indirect fashion. Future identification of direct targets of lola regulation will be informative and necessary to understand the exact mechanism of lola function in PNs.
###end p 62
###begin p 63
###xml 378 386 378 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink">collier </italic>
###xml 520 528 520 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">collier </italic>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 675 679 675 679 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cut </italic>
###xml 862 864 862 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1053 1055 1053 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
The idea that TFs can differentially control fate specification and wiring specificity is consistent with the model of a hierarchical TF code that determines wiring specificity. It is interesting to consider the possibility that some TFs may be used at multiple points during identity and wiring specification. In neuron sub-type specification in the ventral nerve cord, the TF collier specifies the precursors of the Ap neuron subset, but must be turned-off in three of the four Ap cells as subsequent participation of collier in a multi-protein complex later in development defines a unique sub-type of Ap neurons [33]. During development of the peripheral nervous system, cut specifies sensory neuron identity and is required again later in development at different levels in subpopulations of dendritic arborization neurons to specify subclass arborization [34]. Similarly, in vPN development, the TF Cut is necessary in the neuroblast for generation of the correct number of vPNs and postmitotically for specific targeting of the VA1lm glomerulus [14]. Temporal regulation and multi-functionality of TFs are possible mechanisms to limit the required number of genes in a TF code while still uniquely specifying cell identity. Lola is a potential candidate for a TF that may function in this way, both specifying cell identity and playing more specific roles later in development in regulating wiring specificity.
###end p 63
###begin title 64
Methods
###end title 64
###begin title 65
Fly stocks and reagents
###end title 65
###begin p 66
###xml 48 50 48 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 179 185 179 185 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ore76 </sup>
###xml 274 281 274 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ore119 </sup>
###xml 394 399 394 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink">orc4 </sup>
###xml 481 482 481 482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 480 484 480 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink">5<italic>D</italic>2 </sup>
###xml 514 519 514 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 591 596 591 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 612 623 612 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola A </italic>
###xml 628 639 628 639 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola T </italic>
###xml 647 658 647 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola T </italic>
###xml 696 698 696 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 699 701 699 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 702 704 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 730 741 730 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola L </italic>
###xml 786 793 786 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola L </italic>
###xml 833 835 833 835 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 872 874 872 874 <sub xmlns:xlink="http://www.w3.org/1999/xlink">0 </sub>
###xml 925 927 925 927 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
MARCM stocks used were as previously published [35]. Gal4-GH146 and Gal4-Mz19 are available from the Bloomington Stock Center, and Gal4-NP3529 is from the Kyoto Stock Center. lolaore76 (early stop codon in BTB domain predicted to be protein null for all Lola isoforms), lolaore119 (Pro712 to Leu mutation in the Zn-finger linker region of isoform L predicted to reduce DNA binding by 95%), lolaorc4 (C to T transition introduces an early stop in amino acid 771 of isoform K), lola5D2 (P-element insertion into the lola promoter predicted to be strongly hypomorphic allele and eliminate most lola transcription), UAS-lola A (X), UAS-lola T (X) and UAS-lola T (III) have been described previously [16,24,25]. We generated three new UAS-lola L lines with insertions on chromosome III. The lola L coding region was cloned into p [UAST] [36] and injected into embryos. Single G0 males were crossed to yw; Pin/CyO virgins. Single F1 males with red eyes were crossed to yw; Pin/CyO virgins to establish stocks and identify the insertion chromosome.
###end p 66
###begin p 67
###xml 135 150 135 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-mCD8a::GFP </italic>
###xml 220 221 220 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink">x</sup>
###xml 230 245 230 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-mCD8a::GFP </italic>
###xml 266 271 266 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 340 355 340 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-mCD8a::GFP </italic>
###xml 360 365 360 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ORC4 </sup>
###xml 415 419 415 419 <sup xmlns:xlink="http://www.w3.org/1999/xlink">orc4</sup>
###xml 428 443 428 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-mCD8a::GFP </italic>
###xml 485 499 485 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-mCD8a::GFP</italic>
###xml 563 577 563 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-mCD8a::GFP</italic>
###xml 605 607 605 607 <sup xmlns:xlink="http://www.w3.org/1999/xlink">x </sup>
###xml 608 619 608 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola A </italic>
###xml 634 644 634 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola A</italic>
###xml 650 653 650 653 <sup xmlns:xlink="http://www.w3.org/1999/xlink">122</sup>
###xml 655 669 655 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-mCD8a::GFP</italic>
###xml 705 720 705 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-mCD8a::GFP </italic>
###xml 721 732 721 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola L </italic>
###xml 751 761 751 761 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola T</italic>
###xml 767 770 767 770 <sup xmlns:xlink="http://www.w3.org/1999/xlink">122</sup>
###xml 772 786 772 786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-mCD8a::GFP</italic>
###xml 822 837 822 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-mCD8a::GFP </italic>
###xml 838 849 838 849 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola T </italic>
###xml 875 878 875 878 <sup xmlns:xlink="http://www.w3.org/1999/xlink">122</sup>
###xml 880 894 880 894 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-mCD8a::GFP</italic>
###xml 930 944 930 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-mCD8a::GFP</italic>
###xml 946 957 946 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola T </italic>
###xml 958 969 958 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola L </italic>
###xml 989 992 989 992 <sup xmlns:xlink="http://www.w3.org/1999/xlink">122</sup>
###xml 994 1008 994 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-mCD8a::GFP</italic>
###xml 1044 1058 1044 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-mCD8a::GFP</italic>
###xml 1060 1071 1060 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola L </italic>
###xml 1072 1083 1072 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola A </italic>
###xml 1091 1101 1091 1101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola A</italic>
###xml 1107 1110 1107 1110 <sup xmlns:xlink="http://www.w3.org/1999/xlink">122</sup>
###xml 1112 1126 1112 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-mCD8a::GFP</italic>
###xml 1154 1159 1154 1159 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ORE76</sup>
###xml 1173 1188 1173 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-mCD8a::GFP </italic>
###xml 1189 1200 1189 1200 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola T </italic>
###xml 1208 1218 1208 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola T</italic>
###xml 1224 1227 1224 1227 <sup xmlns:xlink="http://www.w3.org/1999/xlink">122</sup>
###xml 1229 1243 1229 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-mCD8a::GFP</italic>
###xml 1271 1276 1271 1276 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ORE76</sup>
###xml 1290 1305 1290 1305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-mCD8a::GFP </italic>
###xml 1306 1317 1306 1317 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola L </italic>
###xml 1330 1333 1330 1333 <sup xmlns:xlink="http://www.w3.org/1999/xlink">122</sup>
###xml 1335 1349 1335 1349 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-mCD8a::GFP</italic>
###xml 1377 1382 1377 1382 <sup xmlns:xlink="http://www.w3.org/1999/xlink">ORE76</sup>
###xml 1396 1410 1396 1410 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-mCD8a::GFP</italic>
###xml 1412 1423 1412 1423 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola L </italic>
###xml 1450 1453 1450 1453 <sup xmlns:xlink="http://www.w3.org/1999/xlink">122</sup>
###xml 1455 1469 1455 1469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-mCD8a::GFP</italic>
###xml 1496 1497 1496 1497 <sup xmlns:xlink="http://www.w3.org/1999/xlink">x</sup>
Genotypes of flies generated in experiments are as follows: (Lola protein expression time course and Lim1 WT staining) yw; Gal4-GH146, UAS-mCD8a::GFP (GH146 staining and LOF analyses) hsFlpCD8; FRT42D, Gal80/FRT42D, lolax, GH146, UAS-mCD8a::GFP [where x denotes any lola allele] (control GH146 MARCM) hsFlpCD8; FRT42D, Gal80/FRT42D, GH146, UAS-mCD8a::GFP (lolaORC4 LOF analysis) hsFlpCD8; FRT42D, Gal80/FRT42D, lolaorc4, GH146, UAS-mCD8a::GFP (control Mz19 MARCM) hsFlpCD8; Gal4-Mz19, UAS-mCD8a::GFP, FRT42D, Gal80/FRT42D (Mz19 LOF analysis) hsFlpCD8; Gal4-Mz19, UAS-mCD8a::GFP, FRT42D, Gal80/FRT42D, lolax (UAS-lola A misexpression) UAS-lola A/hsFlp122, UAS-mCD8a::GFP; FRT42D, Gal80/FRT42D, Gal4-GH146, UAS-mCD8a::GFP (UAS-lola L (X) misexpression) UAS-lola T/hsFlp122, UAS-mCD8a::GFP; FRT42D, Gal80/FRT42D, Gal4-GH146, UAS-mCD8a::GFP (UAS-lola T (III) misexpression) hsFlp122, UAS-mCD8a::GFP; FRT42D, Gal80/FRT42D, Gal4-GH146, UAS-mCD8a::GFP; UAS-lola T (UAS-lola L misexpression) hsFlp122, UAS-mCD8a::GFP; FRT42D, Gal80/FRT42D, Gal4-GH146, UAS-mCD8a::GFP; UAS-lola L (UAS-lola A rescue) UAS-lola A/hsFlp122, UAS-mCD8a::GFP; FRT42D, Gal80/FRT42D, lolaORE76, Gal4-GH146, UAS-mCD8a::GFP (UAS-lola T rescue) UAS-lola T/hsFlp122, UAS-mCD8a::GFP; FRT42D, Gal80/FRT42D, lolaORE76, Gal4-GH146, UAS-mCD8a::GFP (UAS-lola L rescue) hsFlp122, UAS-mCD8a::GFP; FRT42D, Gal80/FRT42D, lolaORE76, Gal4-GH146, UAS-mCD8a::GFP; UAS-lola L (NP3529 LOF analysis) hsFlp122, UAS-mCD8a::GFP;FRT42D, Gal80/FRT42D, lolax;Gal4-NP3529.
###end p 67
###begin title 68
Clonal and phenotypic analysis
###end title 68
###begin p 69
###xml 45 47 45 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 48 50 48 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 542 544 541 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 703 705 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
MARCM was performed as previously described [30,35]. Clones were induced at 24 h APF for all Gal4 driver lines. Brains were dissected, fixed in 4% paraformaldehyde for 20 minutes at room temperature and stained. Brains were mounted in Slow-Fade Gold or BioMedia Mounting Medium and imaged on a Zeiss LSM Meta 510 system. Z-series were captured in 1 mum sections. Fluorophores were imaged using band-pass filters to remove cross-detection between channels and pseudocolored for ease of viewing. Images were processed and scored using Image J [37] or Zeiss software. Data were analyzed using FileMaker Pro and Microsoft Excel. In all, we scored 48 distinct glomeruli in the AL, based on published models [38]. Glomeruli were considered innervated when dendrites entered the nc82 stained synaptic dense region and elaborated extensions within the glomerulus (that is, a single extension passing through a glomerulus was not enough to warrant scoring as positively innervated).
###end p 69
###begin title 70
Antibodies and staining
###end title 70
###begin p 71
###xml 57 59 57 59 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 60 62 60 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 355 357 355 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 570 572 570 572 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 598 600 598 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 648 650 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 109 112 <span type="species:ncbi:10116">rat</span>
###xml 323 329 <span type="species:ncbi:9986">rabbit</span>
###xml 394 404 <span type="species:ncbi:10141">guinea pig</span>
###xml 445 448 <span type="species:ncbi:10116">rat</span>
###xml 493 499 <span type="species:ncbi:9986">rabbit</span>
###xml 542 547 <span type="species:ncbi:10090">mouse</span>
###xml 580 583 <span type="species:ncbi:10116">rat</span>
###xml 612 617 <span type="species:ncbi:10090">mouse</span>
Antibody staining was performed as previously described [14,39]. The following primary antibodies were used; rat anti-mCD8a (Caltag [Burlingame, California, USA]), 1:100; monoclonal antibody (mAb) nc82 (developed by E Buchner and obtained from the Developmental Studies Hybridoma Bank (DSHB) [Iowa City, Iowa, USA]), 1:30; rabbit anti-Lola common region [24], 1:100; mAb anti-Cut (DSHB), 1:20; guinea pig anti-Lim1 (a gift from J Botas), 1:500; rat anti-Islet (a gift from J Skeath), 1:1,000; rabbit anti-Chip (a gift from D Dorsett), 1:500; mouse monoclonal anti-Acj6 [40], 1:5; rat anti-Drifter [41], 1:3,000; mouse monoclonal 7F1 anti-lola zf5 [21]. Nuclei were counterstained with DAPI (5 mg/ml stock 1:1,000).
###end p 71
###begin title 72
Laser-dissection microscopy and RT-PCR
###end title 72
###begin p 73
White y, w; Gal4-GH146, UAS-CD8::GFP pre-pupa (considered 0 h APF) were collected, covered with optimal cutting temperature compound (Tissue Tek O.C.T. #4583 [Sakura Finetek, Torrance, California, USA]), frozen on dry ice and stored at -80degreesC not longer than 1 month. Blocks were sectioned on a cryostat and sections containing ALs were mounted on PEN membrane slides (Leica #11505158) and stored on dry ice. Slides were put through an EtOH dehydration series (75%, 95%, 100% EtOH 5 minutes each), treated for 2 minutes with xylenes, dried and mounted for LCM capture. PN enriched samples as identified by GFP fluorescence were immediately captured into PCR tube caps on a Leica LCM microscope (model ASLMD) using Laser Microdissection software version 4.4. Tubes were frozen on dry ice and stored at -80degreesC up to one day. RNA was extracted using the Arcturus PicoPuretrade mark RNA Isolation kit (#KIT0204, Mountain View, California, USA) as per the manufacturer's instructions.
###end p 73
###begin p 74
###xml 309 314 303 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 720 722 714 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
The cRNA samples were used as the template for another round of reverse transcription (#18080-051, Invitrogen [Carlsbad, California, USA]), producing a high yield of cDNA. The cDNA samples were aliquoted and stored at -20degreesC before use. Unique primer pairs and Taqman probes were designed for individual lola isoforms. The Taqman probes were synthesized by Integrated DNA Technologies, Inc. (Coralville, Iowa, USA). Microfluidic matrix chips (48 x 48 arrays, Fluidigm (South San Francisco, California, USA) were used to perform real time PCR assays in a high throughput fashion. Each chip allows complete combinatorial tests (48 x 48 = 2,304, N = 48) between N independent cDNA samples and N distinct primer pairs [42]. A separate paper is to be published with more technical details.
###end p 74
###begin title 75
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In situ </italic>
In situ hybridization
###end title 75
###begin p 76
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 123 124 123 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S2">2</xref>
###xml 201 203 201 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 921 929 908 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 975 976 962 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S7">7</xref>
###xml 1283 1287 <span type="species:ncbi:9925">goat</span>
###xml 1295 1300 <span type="species:ncbi:9940">Sheep</span>
###xml 1313 1319 <span type="species:ncbi:9986">rabbit</span>
###xml 1333 1340 <span type="species:ncbi:9031">chicken</span>
###xml 1584 1591 <span type="species:ncbi:9031">chicken</span>
Probes for lola were designed to the common region and isoform specific exons (for primers see Table S6 in additional file 2). Isoforms are referred to based on the previously described naming scheme [16]. Probes were amplified from adult genomic preps or from embryo RNA via RT-PCR, topo-cloned and sequenced to verify identity. DIG-labeled RNA probes were generated from plasmid DNA using the Roche DIG-RNA Labeling Kit (#11175025910, Indianapolis, Indiana, USA) following the manufacturer's protocol. Sense and antisense probes were generated from the same plasmid, taking advantage of the SP6 and T7 dual promoter flanked PCR2.1-Topo (# K460001, Invitrogen) cloning site. Probes were diluted to 10 ng/mul and stored at -80degreesC for up to 6 months. We collected 0 h APF pre-pupa, which were frozen in OCT on dry ice, stored at -80degreesC not more than 1 month and sectioned on a cryostat. An in-depth protocol for in situ hybridization is available in additional file 7. Briefly, slides were fixed in 4% PFA for 15 minutes, washed, acetylated, washed, and pre-hybridized at room temperature. Probes were added at concentrations ranging from 5 ng to 100 ng and slides were incubated 18 h overnight at 55degreesC. Slides were washed, native biotin blocked and blocked in normal goat serum. Sheep anti-DIG or rabbit anti-DIG and chicken anti-GFP primaries were added and incubated overnight at 4degreesC. Slides were washed, treated with a tyramide signal amplification kit for DIG signal detection (Dako #K0620 [Carpinteria, California, USA]), then incubated with secondary anti-chicken antibody. Slides were washed, mounted and imaged.
###end p 76
###begin title 77
Competing interests
###end title 77
###begin p 78
S Quake is a co-founder, consultant, and equity holder of Fluidigm Corporation. All other authors declare that they have no competing interests.
###end p 78
###begin title 79
Authors' contributions
###end title 79
###begin p 80
###xml 279 287 279 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 316 324 316 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 756 760 756 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 760 763 760 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ORE</italic>
###xml 764 765 764 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 760 767 760 767 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ORE</italic>5<italic>D</italic>2 </sup>
Maria Spletter designed the study, wrote the manuscript, and performed or participated in all experiments. Justin Liu participated in Lola antibody staining experiments, Gal4-GH146 driver characterization at larval time-points, and MARCM experiments. Helen Su helped develop the in situ protocol and participated in in situ hybridization experiments. Jian Liu helped conceive of and design and participated in LCM RT-PCR experiments. Stephen Quake helped conceive of and participated in the design and analysis of LCM RT-PCR experiments. Edward Giniger helped revise the manuscript and provided initial reagents and intellectual input for the study. Takaki Komiyama originally conceived of the study, performed initial PN phenotype characterization of the lolaORE5D2 allele and helped revise the manuscript. Liqun Luo participated in the overall design and coordination of the study and helped write the manuscript. All authors have read and approved the final manuscript.
###end p 80
###begin title 81
Supplementary Material
###end title 81
###begin title 82
Additional file 1
###end title 82
###begin p 83
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 140 144 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 144 147 144 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ore</italic>
###xml 148 149 148 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 144 150 144 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ore</italic>5<italic>D</italic>2</sup>
###xml 152 156 152 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 156 159 156 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">orc</italic>
###xml 156 160 156 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>orc</italic>4</sup>
###xml 166 170 166 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 170 173 170 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ore</italic>
###xml 170 177 170 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ore</italic>119 </sup>
Additional lola mutant allele MARCM analysis demonstrating dendritic targeting defects. Supplemental Figure S1 showing targeting defects in lolaore5D2, lolaorc4, and lolaore119 mutant PNs.
###end p 83
###begin p 84
Click here for file
###end p 84
###begin title 85
Additional file 2
###end title 85
###begin p 86
###xml 160 164 160 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 164 168 164 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 172 176 172 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 176 179 176 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ORE</italic>
###xml 180 181 180 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 176 186 176 186 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>ORE</italic>5<italic>D</italic>20-/-</sup>
###xml 434 442 434 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
Supplemental Tables S1-S6. Supplemental tables and legends referenced in the main text. This includes a semi-quantitative analysis of axon targeting defects in lola-/- and lolaORE5D20-/-, a complete summary of DL1 dendrite and axon phenotypes by allele as percentage affected, a complete summary of vPN dendritic phenotypes by allele as percentage targeted correctly, clonal frequencies for MARCM experiments and primer sequences for in situ hybridization probes.
###end p 86
###begin p 87
Click here for file
###end p 87
###begin title 88
Additional file 3
###end title 88
###begin p 89
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 24 32 24 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 39 50 39 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 122 130 122 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 155 160 155 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
Additional lola isoform in situ in the Drosophila brain. Supplemental Figure S2 showing controls and verification for our in situ technique and additional lola isoform hybridization results.
###end p 89
###begin p 90
Click here for file
###end p 90
###begin title 91
Additional file 4
###end title 91
###begin p 92
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 47 58 47 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 138 143 138 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
Additional lola isoform RT-PCR analysis in the Drosophila brain. Supplemental Figure S3 showing addition LCM RT-PCR experiments comparing lola isoform expression at different developmental time points and in different brain tissues.
###end p 92
###begin p 93
Click here for file
###end p 93
###begin title 94
Additional file 5
###end title 94
###begin p 95
###xml 11 14 11 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS</italic>
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 180 190 180 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola A</italic>
###xml 192 203 192 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola L </italic>
###xml 207 217 207 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola T</italic>
Effects of UAS-lola overexpression on adPN and lPN dendrites and axons. Supplemental Figure S4 showing adPN and lPN phenotypes in MARCM clones in a wild-type background expressing UAS-lola A, UAS-lola L and UAS-lola T.
###end p 95
###begin p 96
Click here for file
###end p 96
###begin title 97
Additional file 6
###end title 97
###begin p 98
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 31 34 31 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 36 39 36 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS</italic>
###xml 40 45 40 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
###xml 117 121 117 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola</italic>
###xml 121 125 121 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 143 153 143 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola A</italic>
###xml 155 166 155 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola L </italic>
###xml 170 180 170 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola T</italic>
adNB and lNB phenotypes in lola-/-, UAS-lola MARCM clones. Supplemental Figure S5 showing adPN and lPN phenotypes in lola-/- clones expressing UAS-lola A, UAS-lola L and UAS-lola T.
###end p 98
###begin p 99
Click here for file
###end p 99
###begin title 100
Additional file 7
###end title 100
###begin p 101
###xml 17 25 17 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 115 123 115 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 140 151 140 151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
Protocol for RNA in situ hybridization in fly larval/pupal/adult tissues. Our detailed protocol for performing RNA in situ hybridization on Drosophila at later developmental time points.
###end p 101
###begin p 102
Click here for file
###end p 102
###begin title 103
Additional file 8
###end title 103
###begin p 104
Legends for supplemental Figures S1-S5. All supplemental figure titles and legends.
###end p 104
###begin p 105
Click here for file
###end p 105
###begin title 106
Acknowledgements
###end title 106
###begin p 107
###xml 270 278 270 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 434 445 434 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UAS-lola L </italic>
###xml 543 548 543 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lola </italic>
We thank all members of the Luo lab for useful discussion and insights on this project. In particular, we thank Y Chou, E Hoopfer, O Schuldiner, J Wu, C Potter, B Tasic and D Berdnik for comments on the manuscript and O Schuldiner and E Hoopfer for contributions to the in situ protocol. We thank the Stanford Dermatology Laser-Capture Microsopy facility for use of their LCM system; D Luginbuhl for embryo injections to generate the UAS-lola L flies; and E Lane Davies and M Fuller for kindly sharing reagents and insights on the function of lola in other tissues. Antibodies were generously provided by E Buchne, J Botas, D Dorsett, J Skeath and K Johansen. This work was supported by NIH grants to LL. MS is supported by an NIH-NRSA. LL and SQ are investigators of the Howard Hughes Medical Institute.
###end p 107
###begin article-title 108
Molecular mechanisms of axon guidance
###end article-title 108
###begin article-title 109
Target neuron prespecification in the olfactory map of Drosophila
###end article-title 109
###begin article-title 110
###xml 70 79 <span type="species:ncbi:7955">zebrafish</span>
In vivo imaging reveals dendritic targeting of laminated afferents by zebrafish retinal ganglion cells
###end article-title 110
###begin article-title 111
Developmental origin of wiring specificity in the olfactory system of Drosophila
###end article-title 111
###begin article-title 112
Development of wiring specificity in the olfactory system
###end article-title 112
###begin article-title 113
Wiring specificity in the olfactory system
###end article-title 113
###begin article-title 114
Representation of the glomerular olfactory map in the Drosophila brain
###end article-title 114
###begin article-title 115
Spatial representation of the glomerular map in the Drosophila protocerebrum
###end article-title 115
###begin article-title 116
Comprehensive Maps of Drosophila Higher Olfactory Centers: Spatially Segregated Fruit and Pheromone Representation
###end article-title 116
###begin article-title 117
Dendritic patterning by Dscam and synaptic partner matching in the Drosophila antennal lobe
###end article-title 117
###begin article-title 118
Diverse functions of N-cadherin in dendritic and axonal terminal arborization of olfactory projection neurons
###end article-title 118
###begin article-title 119
Graded expression of semaphorin-1a cell-autonomously directs dendritic targeting of olfactory projection neurons
###end article-title 119
###begin article-title 120
From lineage to wiring specificity. POU domain transcription factors control precise connections of Drosophila olfactory projection neurons
###end article-title 120
###begin article-title 121
Intrinsic control of precise dendritic targeting by an ensemble of transcription factors
###end article-title 121
###begin article-title 122
Gradients of the Drosophila Chinmo BTB-zinc finger protein govern neuronal temporal identity
###end article-title 122
###begin article-title 123
Alternative splicing of lola generates 19 transcription factors controlling axon guidance in Drosophila
###end article-title 123
###begin article-title 124
Alternative trans-splicing of constant and variable exons of a Drosophila axon guidance gene, lola
###end article-title 124
###begin article-title 125
Drosophila lola encodes a family of BTB-transcription regulators with highly variable C-terminal domains containing zinc finger motifs
###end article-title 125
###begin article-title 126
POZ for effect--POZ-ZF transcription factors in cancer and development
###end article-title 126
###begin article-title 127
The histone H4 acetyltransferase MOF uses a C2HC zinc finger for substrate recognition
###end article-title 127
###begin article-title 128
A developmentally regulated splice variant from the complex lola locus encoding multiple different zinc finger domain proteins interacts with the chromosomal kinase JIL-1
###end article-title 128
###begin article-title 129
Molecular cloning and characterization of a transcription factor for the copia retrotransposon with homology to the BTB-containing lola neurogenic factor
###end article-title 129
###begin article-title 130
###xml 29 52 <span type="species:ncbi:7227">Drosophila melanogaster</span>
A protein interaction map of Drosophila melanogaster
###end article-title 130
###begin article-title 131
lola encodes a putative transcription factor required for axon growth and guidance in Drosophila
###end article-title 131
###begin article-title 132
LOLA has the properties of a master regulator of axon-target interaction for SNb motor axons of Drosophila
###end article-title 132
###begin article-title 133
Misexpression screen for genes altering the olfactory map in Drosophila
###end article-title 133
###begin article-title 134
Lola regulates midline crossing of CNS axons in Drosophila
###end article-title 134
###begin article-title 135
Epigenetic silencers and Notch collaborate to promote malignant tumours by Rb silencing
###end article-title 135
###begin article-title 136
Identification of genetic loci that interact with cut during Drosophila wing-margin development
###end article-title 136
###begin article-title 137
Mosaic analysis with a repressible cell marker for studies of gene function in neuronal morphogenesis
###end article-title 137
###begin article-title 138
Nerfin-1 is required for early axon guidance decisions in the developing Drosophila CNS
###end article-title 138
###begin article-title 139
Steroid hormone-dependent transformation of polyhomeotic mutant neurons in the Drosophila brain
###end article-title 139
###begin article-title 140
Specification of neuronal identities by feedforward combinatorial coding
###end article-title 140
###begin article-title 141
Different levels of the homeodomain protein cut regulate distinct dendrite branching patterns of Drosophila multidendritic neurons
###end article-title 141
###begin article-title 142
A protocol for mosaic analysis with a repressible cell marker (MARCM) in Drosophila
###end article-title 142
###begin article-title 143
Targeted gene expression as a means of altering cell fates and generating dominant phenotypes
###end article-title 143
###begin article-title 144
###xml 57 80 <span type="species:ncbi:7227">Drosophila melanogaster</span>
Three-dimensional reconstruction of the antennal lobe in Drosophila melanogaster
###end article-title 144
###begin article-title 145
###xml 26 49 <span type="species:ncbi:7227">Drosophila melanogaster</span>
A protocol for dissecting Drosophila melanogaster brains for live imaging or immunostaining
###end article-title 145
###begin article-title 146
Regulation of central neuron synaptic targeting by the Drosophila POU protein, Acj6
###end article-title 146
###begin article-title 147
drifter, a Drosophila POU-domain transcription factor, is required for correct differentiation and migration of tracheal cells and midline glia
###end article-title 147
###begin article-title 148
Solving the "world-to-chip" interface problem with a microfluidic matrix
###end article-title 148

